Schistosomiasis induced-changes in glutathione levels and glutathione reductase/glutathione S-transferase activities in human liver

Biomedical Letters

Volumn 56, Issue 222, 1997, Pages 119-127

  Sheweita, S A ^a   Habib, S L ^a   Mostafa, M H ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Glutathione; Glutathione S transferase; Schistosomiasis; Serum aminotransferases

Indexed keywords

EID: 0031326768     PISSN: 0961088X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ABDEL-TAWAB G., Aboul-Azm T. and Ebid S. 1986. The correlation between certain tryptophan metabolites and the N-nitrosamine content in the urine of bilharzial bladder cancer patients. J. Urol. 135 826-30.
2. ANDERS M. 1991. Glutathione-dependent bioactivation of xenobiotics. FASEB J. 4 87-92.
3. ANDERS M., Lash L. and Dekant W. 1988. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. CRC Crit. Rev. Toxicol. 18 311-42.
4. BADAWI A. and Mostafa M. H. 1993. Possible mechanisms of alteration in the capacities of carcinogen metabolizing enzymes during schistosomiasis and their role in bladder cancer induction. J. Intern. Med. Res. 21 281-305.
5. BOYER T. and Kenney W. 1985. Preparation, characterization and properties of glutathione S-transferase. In Biochemistry, Pharmacology and Toxicology, pp 297-363. Edited by D. Zakin and D. Vessey. John Wiley and Sons Inc., New York.
6. CHEEVER A., Kuntz R. and Moor J. 1979. Carcinoma of the urinary bladder in Schistosoma haematobium infection. Animal model: proliferative urothelial lesions in nonhuman primates infected with Schistosoma haematobium. Am. J. Path. 84 673-76.
7. CHEN M. and Mott K. 1989. Progress of assessment of morbidity due to Schistosoma haematobium infection: a review of recent literature. Trop. Disease Bull. 48 2643-8.
8. DEKANT W., Vanvakas S. and Anders M. 1990. Biosynthesis, bioactivation and mutagenicity of S-conjugates. Toxicol. Lettters 53 53-8.
9. DIMMETTE R., Elwi A. and Sproat H. 1956. Relationship of schistosomiasis and adenocarcinoma of large intestine. Am. J. clin. Path. 26 266-76.
10. EL-BOLKAINY M., Mokhtar N. and Ghoneim M. 1981. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer Res. 48 2643-8.
11. EL-MERZABANI M., Al-Aaser A. and Zakhary N. A. 1979. Study on the aetiological factors of bilharzial bladder cancer in Egypt. I. Nitrosamines and their precursors in urine. Eur. J. Cancer 15 287-91.
12. EL-MUELHI M. and Mansour M. 1990. Hepatic drug conjugation and deconjugation systems in hepatosplenic schistosomiasis. Biochem. Pharmacol. 40 1923-5.
13. FERGUSSON A. 1911. Associated bilharziasis and malignant disease of the urinary bladder with observation on a series of forty cases. J. Path. Bact. 16 76-94.
14. FORTSON W., Tedesco F. and Starnes F. 1985. Marked elevation of serum transaminase activity associated with extrahepatic biliary tract disease. J. clin. Gastroenterol. 7 502-15.
15. 1-DNA binding in livers and kidney of male rats and hamsters pretreated with buthionine sulfoximine and diethylmaleate. Cancer Letters 76 25-30.
16. GOPALAN P., Jensen D. and Lotlikar P. 1992. Glutathione conjugation of microsomes-mediated and synthetic aflatoxin B1-8,9-oxide by purified glutathione S-transferases from rats. Cancer Letters 64 225-33.
17. GUENGERICH F. 1988. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48 2946-54.
18. HABIG W., Pabst M. and Jakoby W. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. biol. Chem. 249 7130-9.
19. HOWIE A., Forrester L. and Glancey M. 1990. Glutathione S-transferase and glutathione peroxidase expression in normal and tumor human tissues. Carcinogenesis 11 451-8.
20. HULTCRANTZ R., Glaumann H. and Lindberg G. 1986. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand. J. Gastroenterol. 21 109-15.
21. ISSEROF H., Sawma J. and Reino D. 1977. Fascioliasis: role of proline in bile duct hyperplasia. Science 198 1157-9.
22. JAMES N., Gay R. and Hilf R. 1980. Influence of estrogen on glutathione levels and glutathione-metabolizing enzymes in uteri and R3230 AC mammary tumors of rats. Biochim. biophys Acta 630 485-96.
23. KAPLAN M. 1972. Alkaline phosphatase. Gastroenterology 62 452-9.
24. KAPLAN M. 1986. Serum alkaline phosphatase. Another piece is added to the puzzle. Hepatology 6 526-31.
25. KAPPUS H. 1986. Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem. Pharmacol. 135 1-6.
26. KETTERER B. 1988. Protective role of glutathione and glutathione S-transferases in mutagenesis and carcinogenesis. Mutat. Res. 202 343-61.
27. LAWSON J. and Wilson R. 1980. Metabolic changes associated with the migration of the schistosomula of Schistosoma mansoni in the mammal host. Parasitol. 81 325-36.
28. 1 to DNA by glutathione S-transferase. Cancer Letters 9 143-9.
29. LOWRY O. H., Rosebrough N. J., Farr A. L. and Randall R. J. 1951. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193 265-75.
30. 1 in the Salmonella/microsome assay. Mutat. Res. 83 15-24.
31. MANNERVIK B. 1985. The isoenzymes of glutathione transferase. Adv. Enzymol. 57 357-17.
32. MEISTER A. and Anderson M. 1983. Glulathione. A. Rev. Biochem. 52 11-20.
33. MITCHELL J., Jollow D. and Potter W. 1973. Acetaminophen-induced hepatic necroses. IV. Protective role of glutathione. J. Pharmac. exp. Ther. 187 211-27.
34. MOSTAFA M. H., Sheweita S. A. and Abdel-Moneam N. 1990. Influence of some anti-inflammatory drugs on the activity of arylhydrocarbon hydroxylase and the cytochrome P-450 content. Environ. Res. 52 77-82.
35. MOSTAFA M. H., Sheweita S. A., El-Kowedy A. and Badawi A. F. 1993. Alterations in the carcinogen metabolizing capacities of mouse liver during Schistosoma mansoni infection. Int. J. Oncology 2 695-9.
36. MOSTAFA M. H. and Sheweita S. A. 1992. Modification of the oxidative N-demethylation of dimethylnitrosamine by various anti-inflammatory drugs. Ramazzini Newslett. 2 5-22.
37. MOSTAFA M., Helmi S. and Badawi A. 1994. Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis 15 619-25.
38. MURRAY G., Burke M. and Ewen S. 1987. Glutathione localization in benign and malignant human breast lesions. Br. J. Cancer 55 605-9.
39. SATO K. 1989. Glutathione transferases as markers of preneoplasia and neoplasia. Adv. Cancer Res. 52 205-55.
40. SCHWARTZ D. 1984. Carcinoma of the uterine cervix and schistosomiasis in West Africa. Gynecol. Oncol. 19 365-70.
41. SENFT A. 1963. Observations on amino acid metabolism of Schistosoma mansoni in a chemically defined medium. Ann. N.Y. Acad. Sci. 113 272-87.
42. SHEA T., Kelley S. and Henner W. 1988. Identification of an anionic form of glutathione transferase present in many human tumor and human tumor cell lines. Cancer Res. 48 527-33.
43. SHERIF M., El-Mawla N. and El-Bolkainy N. 1975. Clinical staging of malignancy in patients suspected to have hepatosplenic schistosomiasis. J. Trop. Med. Hyg. 78 67-70.
44. SHEWEITA S. A. and Mostafa M. H. 1995. Recovery of the hepatic carcinogen-metabolizing capacity in schistosome-infected mice after treatment with anti-schiostosomal praziquantel. Oncology Rep. 2 155-9.
45. SHEWEITA S. A. and Mostafa M. H. 1996. N-nitrosamines and their effects on the hepatic level of glutathione and glutathione reductase and glutathione S-transferase activities in the liver of male mice. Cancer Letters 99 29-34.
46. STENIUS U., Warholm M. and Rannug A. 1989. The role of GSH depletion and toxicity in hydroquinone-induced development of enzyme-altered foci. Carcinogenesis 10 593-9.
47. THOMPSON T., Watkins J. and Gergus Z. 1982. Effect of microsomal enzyme inducers on the soluble enzymes of hepatic phase I biotransformation. Toxicol. appl. Pharmac. 66 400-8.
48. WORLD Health Organization. 1985. The control of schistosomiasis. Report of a WHO Expert Committee, Technical Report Series No. 728, WHO, Geneva.